Treatment with etamsylate reduces haemolactia in lactating dairy cows

Thumbnail
View/Open
Issue date
2019
Author
Fraile Sauce, Lorenzo José
Arcas Pons, Antoni
Jimenez, Luis m.
Mallo, Josep
Armengol Gelonch, Ramon
Suggested citation
Fraile Sauce, Lorenzo José; Arcas Pons, Antoni; Jimenez, Luis m.; Mallo, Josep; Armengol Gelonch, Ramon; . (2019) . Treatment with etamsylate reduces haemolactia in lactating dairy cows. Journal of Dairy Research, 2019, vol. 86, num. 2, p. 1-3. https://doi.org/10.1017/S0022029919000219.
Impact

Google Scholar logo  Google Scholar
Share
Export to Mendeley
Metadata
Show full item record
Abstract
This Research Communication describes the efficacy of etamsylate to reduce haemolactia in dairy cows. A dairy cow with haemolactia produces milk that is reddish or pinkish due to the presence of blood. Haemolactia causes economic loss because bloody milk is rejected by the industry and the consumers.
A total of 58 dairy cows with haemolactia were included in the study and randomly divided into treated (n = 31) and control (n = 27) groups. Treatment consisted of three consecutive daily doses of etamsylate at 15 mg/kg, delivered intramuscularly. Milk production was recorded daily for 7 d, whether or not blood was detected in milk. The mean number of days with the presence of blood in milk in the treatment group was significantly lower (3·4 d) than in the control group (4·9 d). Treatment with etamsylate did not significantly affect milk yield. In conclusion, treatment with etamsylate reduces the number of days blood is observed in milk and it does not have any negative effect on milk production.
URI
http://hdl.handle.net/10459.1/66445
DOI
https://doi.org/10.1017/S0022029919000219
Is part of
Journal of Dairy Research, 2019, vol. 86, num. 2, p. 1-3
Collections